Offer - Urjas Oil for just ₹ 1
Supime 2000/1000 Injection, a prescription drug, is manufactured in various forms such as Injection. Other than this, Supime 2000/1000 Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Supime 2000/1000 Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Supime 2000/1000 Injection can also lead to other problems, which have been listed below. Such side effects of Supime 2000/1000 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Supime 2000/1000 Injection has a Safe effect for pregnant women and Safe effect on lactating mothers. Further, the section on Supime 2000/1000 Injection related warnings talks about Supime 2000/1000 Injection's effects on the liver, heart and kidney.
Supime 2000/1000 Injection is contraindicated in people with pre-existing medical conditions like Kidney Disease, Kidney Disease, Jaundice as it can result in adverse effects. Other contraindications of Supime 2000/1000 Injection have been discussed in the sections ahead.
Additionally, Supime 2000/1000 Injection may also adversely react with other medicines. See below for a complete list.
You should also be aware that Supime 2000/1000 Injection is not safe while driving, and is not addiction.
Supime 2000/1000 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Supime 2000/1000 Injection safe for pregnant women?
There are no side effects of Supime in pregnant women.
Is the use of Supime 2000/1000 Injection safe during breastfeeding?
Supime does not show any harmful effects in lactating women.
What is the effect of Supime 2000/1000 Injection on the Kidneys?
Supime rarely affects the kidneys.
What is the effect of Supime 2000/1000 Injection on the Liver?
Supime is not harmful for the liver.
What is the effect of Supime 2000/1000 Injection on the Heart?
You can take Supime without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Supime 2000/1000 Injection unless your doctor advises you to do so -
Is this Supime 2000/1000 Injection habit forming or addictive?
No, there is no any evidence that Supime 2000/1000 Injection is addictive.
Interaction between Food and Supime 2000/1000 Injection
Eating certain foods may increase the time it takes Supime 2000/1000 Injection to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Supime 2000/1000 Injection
Due to lack of research, there is no information about the side effects of taking Supime 2000/1000 Injection with alcohol.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 291-292
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxipime™ (Cefepime Hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162
